Tag Archives: schizophrenia

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Reasons Patients Doubt Medication-Resistant Delusions in Schizophrenia

Posted on05. Nov, 2010 by .

0

Most Patients Have Self-Doubt; CBT May Help By Icelini Garcia-Sosa, MD and Michael Garrett, MD Psychiatric Times | October 29, 2010 http://www.psychiatrictimes.com/schizophrenia/content/article/10168/1708863  Summary Most delusional patients, even those with high positive symptom scores, may have at least 1 Reason for Doubt (RFD) that precedes a clinical intervention specifically directed toward encouraging doubt. These preexisting “islands […]

Continue Reading

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial

Posted on03. Jun, 2010 by .

0

Wijnand Laan, PhD; Diederick E. Grobbee, MD, PhD; Jean-Paul Selten, MD, PhD; Cobi J. Heijnen, PhD; René S. Kahn, MD, PhD; and Huibert Burger, MD, PhD  http://article.psychiatrist.com/dao_1-login.asp?ID=10006874&RSID=40173234257663  J Clin Psychiatry 2010;71(5):520–527 10.4088/JCP.09m05117yel  © Copyright 2010 Physicians Postgraduate Press, Inc.  Objective: Inflammatory processes may play a role in the pathophysiology of schizophrenia. The aim of this […]

Continue Reading

Thinking Outside a Less Intact Box

Thinking Outside a Less Intact Box

Posted on01. Jun, 2010 by .

0

Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here, we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with a focus on regions where aberrations in dopaminergic […]

Continue Reading

A Systemic Look At Schizophrenia

A Systemic Look At Schizophrenia

Posted on07. Mar, 2010 by .

0

FROM Chemical & Engineering News Serving the chemical, life sciences and laboratory worlds January 18, 2010 Background Because schizophrenia is a psychiatric disorder, its physical manifestations must all be in the brain, right? Maybe not. Proteomic studies using cells from other parts of the body are showing that there might be a systemic aspect of […]

Continue Reading